project id: TCGA-UCEC; case submitter id: TCGA-AP-A1DQ; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.1; spectrophotometer method: UV Spec; age at index: 76; days to birth: -27815; days to death: 1423; ethnicity: not reported; gender: female; race: white; vital status: Dead; year of birth: 1932; age at diagnosis: 27815; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1276.0; figo stage: Stage IIIC1; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1074; days to sample procurement: 0; initial weight: 100.0; portion submitter id: TCGA-AP-A1DQ-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 4.0; percent necrosis: 0.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;